Campus alert status is yellow: For the latest campus alert status, news and resources, visit umassmed.edu/coronavirus

Search Close Search
Search Close Search
Page Menu

RTI Alumni

  • Annabelle Biscans

    Annabelle Biscans, PhD

    Associate Principal Scientist, AstraZeneca

    Former RTI Lab: Postdoctoral Associate, Khvorova Lab
    Training Period: 2016-2020
    Prior Academic Degree Institution: Institute des Biomolécules Max Mousseron, France

    Before joining the Oligonucleotide chemistry team at AstraZeneca R&D in Göteborg, Sweden, Dr. Annabelle Biscans was a postdoctoral associate at the RNA Therapeutics Institute at UMass Medical School in Worcester, MA, USA in Anastasia Khvorova’s lab, one of the pioneers in oligonucleotide therapeutics research. There, she made major contributions to the development of novel chemical platforms for enhancing the delivery and uptake of siRNA therapeutics. Dr. Biscans designed and identified novel conjugated siRNAs that enable safe, sustainable and robust silencing in various extra-hepatic tissues including muscle, heart, and lung. This crucial discovery allows for the targeting of several new targets for therapeutic intervention and advance the oligonucleotide therapeutics field.

  • Andrew Coles

    Andrew Coles, PhD

    Scientist, Alexion Pharmaceuticals

    Former RTI Lab: Postdoctoral Associate, Khvorova Lab
    Training Period: 2012 - 2019
    Prior Academic Degree Institution: UMass Medical School 

  • Marie-Cecile Didiot

    Marie-Cecile Didiot, PhD

    Senior Scientist, Myeloid Therapeutics

    Former RTI Lab: Postdoctoral Associate, Khvorova Lab
    Training Period: 2013 - 2019
    Prior Academic Degree Institution: The University of Strasbourg, France

  • Bruno MDC Godhino

    Bruno MDC Godhino, PhD

    Atalanta Therapeutics

    Former RTI Lab: Postdoctoral Associate, Khvorova Lab
    Training Period: 2015-2021
    Prior Academic Degree Institution: University College Cork, Ireland

  • Reka Haraszti

    Reka Haraszti, MD, PhD

    Resident, Eberhard-Karls-Universität Tübingen, Department of Medicine, Internal Medicine II (Hematology-Oncology)

    Former RTI Lab: Doctoral Candidate, Khvorova Lab
    Training Period: 2013 - 2018
    Prior Academic Degree Institution: Completed MD at Semmelweis University School of Medicine, Budapest, Hungary 

  • Matthew Hassler

    Matthew Hassler, PhD

    Principal Scientist, Atalanta Therapeutics

    Former RTI Lab: Postdoctoral Associate & Instructor, Khvorova Lab
    Training Period: 2013 - 2020
    Prior Academic Degree Institution: McGill University, Canada

  • Socheata Ly

    Socheata Ly, PhD

    Scientist, mRNA Technologies at Myeloid Therapeutics

    Former RTI Lab: Doctoral Candidate, Postdoctoral Associate, Khvorova Lab
    Training Period: 2013 - 2021
    Prior Academic Degree Institution: Clark University

  • Mehran Nikan

    Mehran Nikan, PhD

    Principal Scientist, Ionis Pharmaceuticals

    Former RTI Lab: Postdoctoral Associate, Khvorova Lab
    Training Period: 2013 - 2017
    Prior Academic Degree Institution: University of British Columbia, Canada

  • Maire Osborn

    Maire Osborn, PhD

    Associate Director, Neuro Discovery, Dicerna

    Former RTI Lab: Postdoctoral Associate, Khvorova Lab
    Training Period: 2013-2018
    Prior Academic Degree Institution: Institute des Biomolécules Max Mousseron, France

    Dr. Maire Osborn's interest in drug development began during her undergraduate training in chemistry at McGill University. She then moved cross-country to pursue graduate studies at the University of Oregon. During an early rotation with Dr. Jim Remington, she crystallized and solved the structure of a pink GFP-family protein, which solidified her enthusiasm for structural biology. Her graduate work with Dr. Vickie DeRose involved a biochemical investigation of cellular RNA crosslinking and structural/functional perturbation by platinum (II) anticancer therapeutics. During this time, she frequently attended the RNA Society meetings, and realized that she could combine her dual interests in RNA and drug development within the field of RNA therapeutics. This led her to pursue a postdoctoral position with Dr. Anastasia Khvorova at the RNA Therapeutics Institute at UMass Medical School. Upon completing her postdoc, she joined Dicerna as a Scientist and worked her way up to the Director of Neuro Discovery within a few short years.

  • Loïc Roux

    Loïc Roux, PhD

    Principal Scientist, Nucleic Acid Therapeutic Accelerator

    Former RTI Lab: Postdoctoral AssociateKhvorova Lab
    Training Period: 2013 - 2017
    Prior Academic Degree Institution: Aix-Marseille University, France